Abstract
The next few decades will witness a large increase in the number of older people in the population, principally those aged 80 and over. This age group also has the highest prevalence of disease and disability. Therefore, one might expect that the evidence base on how best to treat this group would be well established, but this is not the case. Older people, especially those with physical and mental health comorbidities, continue to be unjustifiably excluded from clinical trials [1,2]. This raises the question as to whether the exclusion of older people from such investigations can be considered as ageist and whether, as a consequence, older people suffer from age discrimination
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
